Form 4: Exact Sciences EVP Aaron Bloomer Reports Acquisition of Restricted Stock Units

Aaron Bloomer, EVP and CFO of Exact Sciences, reports the acquisition of 28,779 restricted stock units (RSUs) on February 24, 2025, according to a Form 4 filing.

Summary

• On February 26, 2025, a Form 4 filing was submitted to the SEC by Aaron Bloomer, EVP and Chief Financial Officer of Exact Sciences Corp.
• The report details a transaction on February 24, 2025, where Bloomer acquired 28,779 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of common stock each.
• The RSUs vest in four equal annual installments starting on February 27, 2026.
• The filing also includes an exhibit for a Power of Attorney, effective as of April 4, 2024, granting Mark Busch, James Herriott, and Patrick Rogers the authority to execute Forms 3, 4, and 5 on Bloomer's behalf.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard SEC filing related to executive compensation. The acquisition of RSUs is generally viewed as a positive, but it's a routine occurrence.

Positives

• The acquisition of restricted stock units by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units suggests a multi-year commitment from the executive.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units to align management's interests with those of shareholders.
• Vesting schedules are a common mechanism to incentivize long-term performance.

Stakeholder Impact

• Shareholders may view the acquisition of restricted stock units by a key executive as a positive sign of confidence in the company's future.

Key Dates

Keywords

Form 4, restricted stock units, EXAS, Exact Sciences, Aaron Bloomer, EVP, CFO, beneficial ownership, SEC filing, Power of Attorney